Anti-Breast Cancer Activity on MCF-7 Cells of Melittin from Indonesia's Apis cerana: An In Vitro Study
- PMID: 34967571
- PMCID: PMC9080376
- DOI: 10.31557/APJCP.2021.22.12.3913
Anti-Breast Cancer Activity on MCF-7 Cells of Melittin from Indonesia's Apis cerana: An In Vitro Study
Abstract
Objective: Breast cancer is the most common case of cancers. Apitheraphy has been traditionally used for abundance diseases. This study aims to evaluate and compare the anti-breast cancer activity of melittin from Indonesia's Apic cerana as a potential drug for treating breast cancer.
Methods: Apis cerana bee venom (BV) was collected from a bee farm in Cikurutung, Bandung using an electrical venom device. The BV was then purified using the ÄKTA Start system and HiTrap™ SP HP cation exchange chromatography column. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was used to identify melittin based on its molecular mass and lowry's protein assay to measure melittin concentration. Melittin cytotoxicity was measured with brine shrimp lethality test (BSLT), while MCF-7 breast cancer cells MTT assay was used to measure its anti-breast cancer activity, based on inhinition rate.
Results: 95.432 μg/mL melittin is purified from 62.8 mg/L BV, using cation exchange chromatography. Melittin in vitro analysis with MCF-7 MTT assay is used to determine anti-breast cancer activity in dose dependent manner. Furthermore, melttin BSLT result showed a LC50 16.67675 μg/mL. Therefore, the MTT assay was conducted in 5, 10 and 15 μg/mL with MCF-7 inhibition values of 0.768 ± 0.014, 3.303 ± 0.011, and 35.714 ± 0.009 %, respectively.
Conclusion: Indonesia's Apis cerana has the potential to be used as a therapeutic peptide for breast cancer treatment.
Keywords: Apis cerana; MCF-7 Cells; anti-cancer; melittin.
Figures



Similar articles
-
Functional characterization of naturally occurring melittin peptide isoforms in two honey bee species, Apis mellifera and Apis cerana.Peptides. 2014 Mar;53:185-93. doi: 10.1016/j.peptides.2014.01.026. Epub 2014 Feb 8. Peptides. 2014. PMID: 24512991
-
Anti-metastatic Effects of Bee Venom and Melittin in Breast Cancer Cells by Upregulation of BRMS1 and DRG1 Genes.Chem Biol Drug Des. 2024 Oct;104(4):e14637. doi: 10.1111/cbdd.14637. Chem Biol Drug Des. 2024. PMID: 39396919
-
Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells.Food Chem Toxicol. 2014 Jun;68:218-25. doi: 10.1016/j.fct.2014.03.022. Epub 2014 Mar 25. Food Chem Toxicol. 2014. PMID: 24675423
-
Bee Venom Components as Therapeutic Tools against Prostate Cancer.Toxins (Basel). 2021 May 7;13(5):337. doi: 10.3390/toxins13050337. Toxins (Basel). 2021. PMID: 34067049 Free PMC article. Review.
-
Anti-Tumor Effects of Melittin and Its Potential Applications in Clinic.Curr Protein Pept Sci. 2019;20(3):240-250. doi: 10.2174/1389203719666180612084615. Curr Protein Pept Sci. 2019. PMID: 29895240 Review.
Cited by
-
Structural insights and predictive modelling of a novel anti-HER2 scFv and Leptulipin: a newly designed immunotoxin protein for HER2 positive cancers.Toxicol Res (Camb). 2025 May 24;14(3):tfaf060. doi: 10.1093/toxres/tfaf060. eCollection 2025 Jun. Toxicol Res (Camb). 2025. PMID: 40416555
-
Can Bee Venom Be Used as Anticancer Agent in Modern Medicine?Cancers (Basel). 2023 Jul 21;15(14):3714. doi: 10.3390/cancers15143714. Cancers (Basel). 2023. PMID: 37509375 Free PMC article. Review.
-
Bee Venom-Loaded Niosomes as Innovative Platforms for Cancer Treatment: Development and Therapeutical Efficacy and Safety Evaluation.Pharmaceuticals (Basel). 2024 Apr 29;17(5):572. doi: 10.3390/ph17050572. Pharmaceuticals (Basel). 2024. PMID: 38794142 Free PMC article.
-
Pharmacological effects and mechanisms of bee venom and its main components: Recent progress and perspective.Front Pharmacol. 2022 Sep 27;13:1001553. doi: 10.3389/fphar.2022.1001553. eCollection 2022. Front Pharmacol. 2022. PMID: 36238572 Free PMC article. Review.
-
Delivery of Melittin as a Lytic Agent via Graphene Nanoparticles as Carriers to Breast Cancer Cells.J Funct Biomater. 2022 Dec 7;13(4):278. doi: 10.3390/jfb13040278. J Funct Biomater. 2022. PMID: 36547538 Free PMC article.
References
-
- Alalawy AI, El Rabey HA, Almutairi FM, et al. Effectual Anticancer Potentiality of Loaded Bee Venom onto Fungal Chitosan Nanoparticles. Int J Polym Sci. 2020;2020:1–9.
-
- Badria F, Fathy H, Fatehe A, et al. Evaluate the cytotoxic activity of honey, propolis, and bee venom from different localities in Egypt against liver, breast, and colorectal cancer. J Apither. 2017;2:1.
-
- Bagyalakshmi B, Priyadarshini SL, Balamurugan A. Anticancer Activity of Bee Venom against Lung Cancer Cell Line (A549 Cells) Enhanced by Iron Oxide Nanoparticles Synthesized from Syzygium Aromaticum. J Drug Deliv Ther. 2019;9:248–54.
-
- Bogdanov S. The Bee Venom Book, Chapter 1. 2016.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous